‘FLAGSHIP’ study opened at Sylvester Comprehensive Cancer Center’s Myeloma Institute

C. Ola Landgren, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on X:

“Exciting ‘FLAGSHIP’ study opened at Sylvester Comprehensive Cancer Center’s Myeloma Institute in Miami!

Collaboration with Boston Gene for exact molecular sub-typing and personalized treatment strategies.

See here.“

Source: C. Ola Landgren/X